blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1812456

EP1812456 - ss-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.10.2014
Database last updated on 13.11.2024
Most recent event   Tooltip10.10.2014Application deemed to be withdrawnpublished on 12.11.2014  [2014/46]
Applicant(s)For all designated states
MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN
Robert-Rössle-Strasse 10
13125 Berlin / DE
[2007/31]
Inventor(s)01 / MATTHES, Eckart
Altlandsberger Chaussee 76
15345 Eggersdorf / DE
02 / VON JANTA-LIPINSKI, Martin
Mittelweg 75
12487 Berlin / DE
03 / WILL, Hans
Paul-Sorgestr. 60a
22459 Hamburg / DE
04 / SIRMA, Hüseyin
Am Deich 18
25335 Elmshorn / DE
05 / FUNK, Anneke
Hedberg 37
22301 Hamburg / DE
 [2007/31]
Representative(s)Boeckh, Tobias
Hertin und Partner
Rechts- und Patentanwälte PartG mbB
Kurfürstendamm 54/55
10707 Berlin / DE
[N/P]
Former [2007/31]Boeckh, Tobias
HERTIN Anwaltssozietät Kurfürstendamm 54/55
10707 Berlin / DE
Application number, filing date05803873.821.10.2005
[2007/31]
WO2005EP11555
Priority number, dateDE2004105180421.10.2004         Original published format: DE102004051804
[2007/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006045616
Date:04.05.2006
Language:EN
[2006/18]
Type: A2 Application without search report 
No.:EP1812456
Date:01.08.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 04.05.2006 takes the place of the publication of the European patent application.
[2007/31]
Search report(s)International search report - published on:EP19.10.2006
ClassificationIPC:C07H19/073
[2007/31]
CPC:
C07H19/073 (EP,US); C07H19/06 (US); A61K31/706 (US);
A61K31/7068 (US); A61K45/06 (US); A61P31/18 (EP);
A61P31/20 (EP); A61P35/00 (EP); C07H19/10 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/31]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:ss-L-N4-HYDROXYCYTOSIN-DEOXYNUKLEOSIDEUND IHRE VERWENDUNG ALS PHARMAZEUTISCHE MITTEL ZUR PROPHYLAXE ODER THERAPIE VON VIRALEN ERKRANKUNGEN[2007/31]
English:ss-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES[2007/31]
French:ss-L-N4-HYDROXYCYTOSINE DESOXYNUCLEOSIDES ET LEUR UTILISATION COMME AGENTS PHARMACEUTIQUES DANS LA PROPHYLAXIE OU LE TRAITEMENT DE MALADIES VIRALES[2007/31]
Entry into regional phase02.05.2007National basic fee paid 
02.05.2007Designation fee(s) paid 
02.05.2007Examination fee paid 
Examination procedure02.05.2007Amendment by applicant (claims and/or description)
02.05.2007Examination requested  [2007/31]
25.07.2007Despatch of a communication from the examining division (Time limit: M06)
14.01.2008Reply to a communication from the examining division
17.04.2008Despatch of a communication from the examining division (Time limit: M04)
26.08.2008Reply to a communication from the examining division
29.10.2010Despatch of a communication from the examining division (Time limit: M06)
03.05.2011Reply to a communication from the examining division
11.04.2014Despatch of a communication from the examining division (Time limit: M04)
01.05.2014Application deemed to be withdrawn, date of legal effect  [2014/46]
16.06.2014Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/46]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.07.2007
Fees paidRenewal fee
15.10.2007Renewal fee patent year 03
05.09.2008Renewal fee patent year 04
26.10.2009Renewal fee patent year 05
21.09.2010Renewal fee patent year 06
11.10.2011Renewal fee patent year 07
15.10.2012Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.10.201309   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[PX]CN1626543  ;
 [A]EP0355031  (AKAD WISSENSCHAFTEN DDR [DD]);
 [A]  - HOLLECKER L ET AL, "SYNTHESIS OF .BETA.-ENANTIOMERS OF N4-HYDROXY-3'-DEOXY-PYRIMIDINE NUCLEOSIDES AND THEIR EVALUATION AGAINST BOVINE VIRAL DIARRHOEA VIRUS AND HEPATITIS C VIRUS IN CELL CULTURE", ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, BLACKWELL SCIENTIFIC PUBL., LONDON, GB, (2004), vol. 15, no. 1, ISSN 0956-3202, pages 43 - 55, XP009069354 [A] * figure 2; table 1 *
 [A]  - MANSOUR T S ET AL, "STRUCTURE-ACTIVITY RELATIONSHIP OF PYRIMIDINE HETEROSUBSTITUTED NUCLEOSIDE ANALOGUES", NUCLEOSIDES & NUCLEOTIDES, MARCEL DEKKER, INC, US, (1997), vol. 16, no. 7-9, ISSN 0732-8311, pages 993 - 1001, XP000999032 [A] * see compound 5; page 995 - page 996 *
 [A]  - HERDEWIJN, PIET ET AL, "Synthesis and anti- HIV activity of different sugar-modified pyrimidine and purine nucleosides", JOURNAL OF MEDICINAL CHEMISTRY , 31(10), 2040-8 CODEN: JMCMAR; ISSN: 0022-2623, (1988), XP002391701 [A] * see compound 1g; page 2044 *

DOI:   http://dx.doi.org/10.1021/jm00118a033
 [A]  - WANG P ET AL, "RECENT ADVANCES IN L-NUCLEOSIDES: CHEMISTRY AND BIOLOGY", ANTIVIRAL RESEARCH, ELSEVIER SCIENCE BV., AMSTERDAM, NL, (1998), vol. 46, no. 1/2, ISSN 0166-3542, pages 19 - 44, XP000944025

DOI:   http://dx.doi.org/10.1016/S0166-3542(98)00041-2
 [PX]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2005, no. 76, Database accession no. 2005-735367, XP002394540 & CN1626543 A 20050615 ((REQU-N)) [PX] 1-38 * column A *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.